Affordable Access

Publisher Website

Developing intrathoracic sentinel lymph node mapping with near-infrared fluorescent imaging in non–small cell lung cancer

Authors
Journal
Journal of Thoracic and Cardiovascular Surgery
0022-5223
Publisher
Elsevier
Volume
144
Issue
3
Identifiers
DOI: 10.1016/j.jtcvs.2012.05.072
Disciplines
  • Biology
  • Medicine
  • Physics

Abstract

With poor survival and high recurrence rates, early-stage lung cancer currently appears to be understaged or undertreated, or both. Although sentinel lymph node biopsy is standard for patients with breast cancer and melanoma, its success has been unreliable in non–small cell lung cancer. Sentinel lymph node biopsy might aid in the identification of lymph nodes at the greatest risk of metastasis and allow for more detailed analysis to select for patients who might benefit from adjuvant therapy. The early results in our recent clinical trial of patients with early-stage lung cancer have suggested that near-infrared imaging might offer a platform for reliable sentinel lymph node identification in these patients.

There are no comments yet on this publication. Be the first to share your thoughts.